Auditor
in Clinical Research (ICH-GCP Based Notes)
Definition
An auditor
is an independent person appointed by the sponsor (or sometimes by regulatory
authorities) to conduct a systematic and in-depth examination
of:
- Trial conduct
- Compliance with the protocol
- Compliance with Good Clinical Practice (GCP)
- Standard Operating Procedures (SOPs)
- Applicable regulatory requirements
Audit
visits are usually pre-arranged, but may be unannounced
in cases of suspected serious GCP violations, fraud, or malpractice.
Regulatory
Basis
Audits
are guided by:
- International Council
for Harmonisation of Technical Requirements for Pharmaceuticals for Human
Use (ICH-GCP)
- U.S. Food and Drug
Administration (FDA) regulations
- Other
applicable national regulatory authorities
Roles
and Responsibilities of an Auditor
Auditors
perform different types of audits in clinical trials:
1.
Investigational Site Audits
Purpose:
To
evaluate:
- Site
performance
- Compliance
with GCP and protocol
- Adequacy
of documentation
- Level
of sponsor risk
When
Conducted:
- If
the sponsor suspects non-compliance
- Before
regulatory inspection
- As
part of routine quality assurance
Focus
Areas:
- Informed consent process
- Source data verification
- Drug accountability
- Protocol deviations
- Investigator qualifications
- Safety reporting
2.
Clinical Department / Process Audits
Purpose:
To assess
internal clinical trial processes.
Need
for These Audits:
- Preparation for regulatory inspection
- Improve effectiveness and efficiency
- Address management concerns
- Evaluate adherence to SOPs
Evaluates:
- Monitoring
activities
- Documentation
practices
- Communication
systems
- Protocol
implementation
3.
Data Management Audits
Objectives:
- Compare
dataset entries with Case Report Forms (CRFs)
- Review
data validation programs
- Assess
query management system
- Check
file structure and dataset merging
- Evaluate
security and backup procedures
Key
Focus:
- Data integrity
- Accuracy
- Confidentiality
- Audit trails
4.
Safety Department Audits
Auditor
Reviews:
- Sample of Serious Adverse Events (SAEs)
Checks
for:
- Accuracy of reporting and coding
- Timeliness of regulatory submission
- Consistency with adverse event database
- Proper use of safety software systems
- Compliance with pharmacovigilance standards
5.
GCP Laboratory Audits
Auditor
Ensures:
- Research conducted under proper authority
- Scientific validity of procedures
- Protection of subject rights, safety, and well-being
- Equipment calibration and validation
- Proper sample handling and documentation
6.
Sponsor Central File Audits
Includes
Inspection of:
- Sponsor Trial Master File (TMF)
- Contract Research Organizations (CROs)
Purpose:
- Verify compliance with regulations
- Ensure completeness of essential documents
- Confirm validity and reliability of submitted data
May
Be:
- Pre-inspection audits
- For-cause audits
- Routine internal quality audits
Key
Differences (Exam Point – Drug Inspector / Clinical Research)
|
Feature |
Audit |
Inspection |
|
Conducted by |
Sponsor’s QA or independent auditor |
Regulatory authority |
|
Purpose |
Quality improvement & compliance check |
Regulatory enforcement |
|
Frequency |
Planned or for-cause |
Often unannounced |
|
Outcome |
Audit report & CAPA |
Warning letters, penalties |
Important
Points for Exams
- Auditor must be independent of the
clinical trial team.
- Auditor prepares a written audit report.
- Findings require Corrective and Preventive
Action (CAPA).
- Audit trail and documentation are critical.
- Subject safety and data integrity are top priorities.
No comments:
Post a Comment